Two novel anti-von Willebrand factor monoclonal antibodies

Thrombosis Research

Volumn 97, Issue 2, 2000, Pages 3-13

  Spadafora Ferreira, M Ônica ^a   Lopes, Antônio Augusto B ^b   Coelho, Verônica ^a   Guilherme, Luiza ^a   Kalil, Jorge ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FUNDAÇÃO PRÓ SANGUE HEMOCENTRO DE SÃO PAULO   (Brazil)

Author keywords

Coagulation; Endothelial cells; Monoclonal antibodies; Platelet aggregation; von Willebrand Factor

Indexed keywords

MONOCLONAL ANTIBODY; VON WILLEBRAND FACTOR;

ARTICLE; BLOOD CLOTTING; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MONONUCLEAR CELL; PRIORITY JOURNAL; STAINING; THROMBOCYTE AGGLUTINATION; THROMBOCYTE AGGREGATION; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY AFFINITY; CELL CULTURE TECHNIQUES; ENDOTHELIUM, VASCULAR; HUMANS; HYBRIDOMAS; IMMUNOBLOTTING; IMMUNOENZYME TECHNIQUES; LEUKOCYTES, MONONUCLEAR; MICE; MICE, INBRED BALB C; PLATELET AGGREGATION; PRECIPITIN TESTS; RISTOCETIN; TUMOR CELLS, CULTURED; UMBILICAL VEINS; VON WILLEBRAND FACTOR;

EID: 0033989152     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(99)00122-X     Document Type: Article

References (43)

1. Vane J.R., Änggard E.E., Botting R.M. Regulatory functions of the vascular endothelium. N Engl J Med. 323:1990;27-36.
2. Thorgeirsson G., Robertson A.L. The vascular endothelium - Pathologic significance. Am J Pathol. 93:1978;803-848.
3. Hattori R., Hamilton K.K., Fugate R.D., McEver R.P., Sims P.J. Stimulated secretion of endothelial von Willebrand factor is accompanied by rapid redistribution to the cell surface of the intracellular granule membrane protein GMP-140. J Biol Chem. 264:1989;7768-7771.
4. Vischer U.M., Wagner D.D. CD63 is a component of Weibel-Palade bodies of human endothelial cells. Blood. 82:1993;1184-1191.
5. Wagner D.D., Marder V.J. Biosynthesis of von Willebrand protein by human endothelial cells. J Biol Chem. 258:1983;2065-2067.
6. Girma J.P., Meyer D., Verweij C.L., Pannekoek H., Sixma J.J. Structure-function relationship of human von Willebrand factor. Blood. 70:1987;605-611.
7. Bahou W.F., Ginsburg D., Sikkink R., Litwiller R., Fass D.N. A monoclonal antibody to von Willebrand factor (vWF) inhibits factor VIII binding. J Clin Invest. 84:1989;56-61.
8. Kroner P.A., Foster P.A., Fahs S.A., Montgomery R.R. The defective interaction between von Willebrand factor and factor VIII in a patient with type 1 von Willebrand disease is caused by substitution of Arg19 and His54 in mature von Willebrand factor. Blood. 87:1996;1013-1021.
9. Vlot A.J., Koppelman S.J., Meijers J.C.M., Damas C., van der Berg H.M., Bouma B.N., Sixma J.J., Willems G.M. Kinetics of factor VIII-von Willebrand factor association. Blood. 5:1996;1809-1816.
10. Leyte A., Verbeet M.P., Brodniewicz-Proba T., van Mourik J.A., Mertens K. The interaction between human blood-coagulation factor VIII and von Willebrand factor. Characterization of a high-affinity binding site on factor VIII. Biochem J. 257:1989;679-683.
11. Jorieux S., Gaucher C., Piétu G., Cherel G., Meyer D., Mazurier C. Fine epitope mapping of monoclonal antibodies to the NH2-terminal part of von Willebrand factor (vWf) by using recombinant and synthetic peptides. interest for the localization of the factor VIII binding domain Br J Haematol. 87:1994;113-118.
12. Saenko E.L., Scandella D. The acidic region of the factor VIII light chain and the C2 domain together form the high affinity binding site for von Willebrand factor. J Biol Chem. 272:1997;1807-1814.
13. Yokoyama K., Handa M., Oda A., Katayama M., Fujimura Y., Murata M., Kawai Y., Watanabe K., Ikeda Y. Characterization of the novel murine monoclonal anti-von Willebrand factor (vWf) antibody GUR76-23 which inhibits vWf interaction with alpha Ilb beta 3 but not alpha v beta 3 integrin. Biochem Biophys Res Commun. 234:1997;147-152.
14. Isobe T., Hisaoka T., Shimizu A., Okuno M., Aimoto S., Takada Y., Saito Y., Takagi J. Propolypetide of von Willebrand factor is a novel ligand for very late antigen-4 integrin. J Biol Chem. 272:1997;8447-8453.
15. Beacham D., Tram L.P., Shapiro S.S. Cytokine treatment of endothelial cells increases glycoprotein Ib alpha-dependent adhesion to von Willebrand factor. Blood. 89:1997;4071-4077.
16. Kalil J., Crevat D., Fellous M., Drouet J., Courouce A.M., Ropars C. Production d'anticorps monoclonaux anti-HBs. Production et analyses Ann Immunol (Inst Pasteur). 132C:1981;319-326.
17. Crevat D., Kalil J., Rose F., Fellous M. Présence de deux épitopes différents sur la beta2-microglobuline humaine définis par des anticorps monoclonaux. Ann Immunol (Inst Pasteur). 134C:1983;31-42.
18. Jaffe E.A., Nachman R.L., Becker C.G., Minick C.R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest. 52:1973;2745-2756.
19. Jaffe E.A. Culture of human human endothelial cells. Transplant Proc. 12:1980;49-53.
20. Boyum A. Separation of blood leucocytes, granulocytes and lymphocytes. Tissue Antigens. 4:1974;269-274.
21. Danilovs JA, Ayoub G, Terasaki PI. Histocompatibility Testing. In: Terasaki PI, editor. Los Angeles: UCLA Tissue Typing Laboratory; 1980:287.
22. Köhler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 256:1975;495-497.
23. Harlow Ed, Lane D. editors. Antibodies: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1988. p. 283-318.
24. Towbin H., Staehelin T., Bordon J. Eletrophoretic transfer of proteins from polyacrilamide gels to nitrocellulose sheets. Procedure and some applications Proc Natl Acad Sci USA. 76:1979;4350-4354.
25. Girma J.P., Kalafatis M., Piétu G., Lavergnes J.M., Chopek M.W., Edgington T.S., Meyer D. Mapping of distinct von Willebrand domains interacting with platelet GPIb and GPIIb/IIIa and with collagen using monoclonal antibodies. Blood. 67:1986;1356-1366.
26. Coller B.S., Peerschke E.I., Scudder L.E., Sullivan C.A. Studies with a murine monoclonal antibody that abolishes ristocetin-induced binding of von Willebrand factor to platelets. Additional evidence in support of GpIb as a platelet receptor for von Willebrand factor Blood. 61:1983;99-105.
27. Matsushita T., Sadler J.E. Identification of amino acid residues essential for von Willebrand factor binding to platelet glycoprotein Ib. Charged-to-alanine scanning mutagenesis of the A1 domain of human von Willebrand factor. J Biol Chem. 270:1995;13406-13414.
28. Meyer D., Zimmerman T.S., Obert B., Edgington T.S. Hybridoma antibodies to human von Willebrand factor. Br J Haematol. 57:1984;597-608.
29. Goodall A.H., Meyer D. Registry of monoclonal antibodies to factor VIII and von Willebrand factor. Thromb Haemost. 54:1985;878-891.
30. Sultan Y., Avner P., Maisonneuve P., Arnaud D., Jeanneau C. An immunoradiometric assay for factor VIII related antigen (VIIIRAg) using two monoclonal antibodies - comparison with polyclonal rabbit antibodies for use in von Willebrand's disease diagnosis. Thromb Haemost. 52:1984;250-252.
31. Lopes A.A.B., Maeda N.Y., Aiello V.D., Ebaid M., Bydlowski S.P. Abnormal multimeric and oligomeric composition is associated with enhanced endothelial expression of von Willebrand factor in pulmonary hypertension. Chest. 104:1993;1455-1460.
32. Dent J.A., Berkowitz S.D., Ware J., Kasper C.K., Ruggeri Z.M. Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor. Proc Natl Acad Sci USA. 87:1990;6306-6310.
33. Federici A.B., Berkowitz S.D., Lattuada A., Mannucci M. Degradation of von Willebrand factor in patients with acquired clinical conditions in which there is heightened proteolysis. Blood. 81:1993;720-725.
34. Lattuada A., Manucci P.M., Chen C., Legnani C., Palareti G. Transfusion requirements are correlated with the degree of proteolysis of von Willebrand factor during orthotopic liver transplantation. Thromb Haemost. 78:1997;813.
35. Tomisaki S., Ohno S., Ichiyoshi Y., Kuwano H., Maehara Y., Sugimachi K. Microvessel quantification and its possible relation with liver metastasis in colorectal cancer. Cancer. 77:1996;1722-1728.
36. Tanigawa N., Amaya H., Matsumura M., Shimomatsuya T., Horiuchi T., Muraoka R., Iki M. Extent of tumor vascularization correlates with prognosis and hematogenous metastasis in gastric carcinomas. Cancer Res. 56:1996;2671-2676.
37. Kaartinen M., Penttila A., Kovanen P.T. Mast cells accompany microvessels in human coronary atheromas. implications for intimal neovascularization and hemorrhage Atherosclerosis. 123:1996;123-131.
38. Lopes A.A.B., Maeda N.Y. Abnormal degradation of von Willebrand factor main subunit in pulmonary hypertension. Eur Respir J. 8:1995;530-536.
39. Datta Y.H., Romano M., Jacobson B.C., Golan D.E., Serhan C.N., Ewenstein B.M. Peptido-leukotrienes are potent agonists of von Willebrand factor secretion and P-selectin surface expression in human umbilical vein endothelial cells. Circulation. 92:1995;3304-3311.
40. van der Poll T., van Deventer S., Pasterkamp G., van Mourik J.A., Ten Cate J.W. Tumor necrosis factor induces von Willebrand factor release in healthy humans. Thromb Haemost. 67:1992;623-626.
41. Rose M., Hengstenberg C., Yacoub M., Page C. Immunocytochemical markers of activation in cardiac transplant rejection. Eur Heart J. 12:1991;147-150.
42. Taylor P.M., Rose M.L., Yacoub M.H., Pigott R. Induction of vascular adhesion molecules during rejection of human cardiac allografts. Transplantation. 54:1992;451-457.
43. van Son W.J., Brijker F., Elema J.D., Tegzess A.M., van der Meer J. Elevated factor VIII as a marker for vascular type of rejection after renal transplantation. Transplant Proc. 29:1997;161-163.